Epidemiologic studies suggest that the natural history of renal complications consists of a sequence of stages, the first being marked by the appearance of microalbuminuria. The next stage begins when microalbuminuria worsens to overt proteinuria, at which point progressive renal destruction leads to renal failure or premature atherosclerosis. The major factors implicated in the etiology of renal complications include genetic predisposition to hypertension, a variant of the type IV Collagen gene, and environmental exposures such as poor glycemic control and high protein intake. The goal of this research is to test the hypothesis that these several factors are differentially involved at each stage. A two-phase design will be used. The first will be a large case-control study of 1000 individuals with Type I diabetes, 500 with microalbuminuria and 500 with no evidence of nephropathy, to determine risk factors for the development of incipient nephropathy. Genetic predisposition to hypertension will be assessed by the Vmax of Li-Na countertransport in red cells. The genotypes of Type IV collagen will be assessed using certain RFLPs for the collagen IV alpha 1 gene. Usual dietary protein intake will be assessed using a semi-quantitative food frequency questionnaire, and five year history of glycemic control will be assessed using HbA1 and index of hyperglycemia. The second phase of the proposed study will be a follow-up of the group of cases to determine which factors influence progression to overt proteinuria. The results of this research will enable us to identify which factors are influential in the earliest stages of diabetic nephropathy. This will not only increase understanding of the pathophysiology of renal complications in diabetes, but it will also enable us to devise programs aimed at the prevention of the onset of early nephropathy or its progression to established nephropathy, a state which inevitably leads to renal failure or premature atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK041526-01A1
Application #
3242307
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Project Start
1990-02-01
Project End
1995-01-31
Budget Start
1990-02-01
Budget End
1991-01-31
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Skupien, Jan; Smiles, Adam M; Valo, Erkka et al. (2018) Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy. Diabetes Care :
Nowak, Natalia; Skupien, Jan; Smiles, Adam M et al. (2018) Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development. Kidney Int 93:1198-1206
Yamanouchi, Masayuki; Skupien, Jan; Niewczas, Monika A et al. (2017) Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease. Kidney Int 92:258-266
Niewczas, Monika A; Mathew, Anna V; Croall, Stephanie et al. (2017) Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 40:383-390
Krolewski, Andrzej S; Skupien, Jan; Rossing, Peter et al. (2017) Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes. Kidney Int 91:1300-1311
Niewczas, Monika A; Krolewski, Andrzej S (2017) Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390. Diabetes Care 40:e109-e110
Skupien, Jan; Warram, James H; Smiles, Adam M et al. (2016) Patterns of Estimated Glomerular Filtration Rate Decline Leading to End-Stage Renal Disease in Type 1 Diabetes. Diabetes Care 39:2262-2269
Nowak, Natalia; Skupien, Jan; Niewczas, Monika A et al. (2016) Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes. Kidney Int 89:459-67
Pavkov, Meda E; Weil, E Jennifer; Fufaa, Gudeta D et al. (2016) Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes. Kidney Int 89:226-34
Orlov, Steven; Cherney, David Z I; Pop-Busui, Rodica et al. (2015) Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes. Clin J Am Soc Nephrol 10:1136-44

Showing the most recent 10 out of 96 publications